SIRT2 and metabolic dysfunction-associated steatohepatitis: To determine the roles of SIRT2 expression in human liver fibrosis, we examined liver specimens from four stages, from healthy to NASH progression: healthy controls, patients with mild fibrosis (F0, F1), moderate fibrosis (F2), and advanced fibrosis (F3).